Pandolfi, Franco
 Distribuzione geografica
Continente #
NA - Nord America 3.228
EU - Europa 2.874
AS - Asia 1.505
SA - Sud America 250
AF - Africa 16
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.892
Nazione #
US - Stati Uniti d'America 3.194
DE - Germania 830
SG - Singapore 573
CN - Cina 572
SE - Svezia 526
UA - Ucraina 505
BR - Brasile 224
IE - Irlanda 215
IT - Italia 209
FR - Francia 188
ID - Indonesia 123
FI - Finlandia 122
GB - Regno Unito 88
RU - Federazione Russa 82
IN - India 79
TR - Turchia 35
JP - Giappone 23
BE - Belgio 22
CA - Canada 20
HK - Hong Kong 18
NL - Olanda 16
PL - Polonia 16
AU - Australia 15
VN - Vietnam 15
AR - Argentina 11
KR - Corea 11
PK - Pakistan 11
IR - Iran 10
CH - Svizzera 9
ES - Italia 9
MX - Messico 8
IQ - Iraq 7
CL - Cile 6
ZA - Sudafrica 5
DK - Danimarca 4
IL - Israele 4
MK - Macedonia 4
PT - Portogallo 4
RO - Romania 4
CZ - Repubblica Ceca 3
LT - Lituania 3
MA - Marocco 3
PH - Filippine 3
RS - Serbia 3
SA - Arabia Saudita 3
AM - Armenia 2
AT - Austria 2
AZ - Azerbaigian 2
EC - Ecuador 2
IS - Islanda 2
JM - Giamaica 2
KE - Kenya 2
KZ - Kazakistan 2
MY - Malesia 2
NO - Norvegia 2
PE - Perù 2
PY - Paraguay 2
RE - Reunion 2
TN - Tunisia 2
TW - Taiwan 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CO - Colombia 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
HU - Ungheria 1
JO - Giordania 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
NZ - Nuova Zelanda 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.892
Città #
Chandler 515
Ashburn 367
Singapore 290
Jacksonville 262
San Mateo 214
Dublin 207
Wilmington 124
Jakarta 122
Nanjing 111
Ann Arbor 108
Lawrence 89
Boston 82
Cattolica 73
Dearborn 69
Moscow 62
Beijing 57
Houston 57
Woodbridge 52
Fairfield 47
Redwood City 47
Boardman 45
Seattle 42
Detroit 36
New York 36
Marseille 34
Mountain View 34
Nürnberg 33
Hangzhou 32
Lancaster 32
Nanchang 32
Shenyang 32
University Park 31
Hefei 30
Los Angeles 30
Hebei 29
Princeton 23
Shanghai 23
Helsinki 22
Milan 22
Izmir 21
Brussels 20
Bremen 19
Cambridge 19
Chicago 19
Norwalk 19
Jiaxing 18
São Paulo 18
Changsha 17
Guangzhou 17
Munich 17
Rome 17
Tianjin 15
Washington 15
Jinan 14
Kraków 14
Zhengzhou 14
Hong Kong 13
Fremont 12
Düsseldorf 10
Hanoi 10
Pune 10
Simi Valley 10
Ankara 9
Kunming 9
Leawood 9
Rio de Janeiro 9
Busto Arsizio 8
Nuremberg 8
Seoul 8
Bareggio 7
Council Bluffs 7
Encino 7
Frankfurt am Main 7
Indiana 7
London 7
Paris 7
Zola Predosa 7
Bern 6
Brasília 6
Chengdu 6
Edinburgh 6
Falls Church 6
Kish 6
Lahore 6
Milpitas 6
Philadelphia 6
Ypsilanti 6
Ningbo 5
Porto Alegre 5
Stockholm 5
Verona 5
Augusta 4
Florianópolis 4
Goiânia 4
Lauterbourg 4
Montréal 4
North Bergen 4
Prilep 4
Shenzhen 4
Sydney 4
Totale 4.143
Nome #
Can vitamin a mediate immunity and inflammation? 135
Skewed T-cell receptor repertoire: more than a marker of malignancy, a tool to dissect the immunopathology of inflammatory diseases 125
Tissue-infiltrating lymphocytes analysis reveals large modifications of the duodenal "immunological niche" in coeliac disease after gluten-free diet. 123
The role of IL-15 in gastrointestinal diseases: a bridge between innate and adaptive immune response 122
Key Role of DAMP in Inflammation, Cancer, and Tissue Repair 116
Reflux symptoms in wind instrument players. 113
Comment on: Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system. 112
Uncomplicated Diverticular Disease: Innate and Adaptive Immunity in Human Gut Mucosa before and after Rifaximin 109
Role of vitamins D, E and C in immunity and inflammation. 107
How the Intricate Interaction among Toll-Like Receptors, Microbiota, and Intestinal Immunity Can Influence Gastrointestinal Pathology 107
Relationship between gastric localization of hepatitis C virus and mucosa-associated lymphoid tissue in Helicobacter pylori infection 106
Recent insights in primary immunodeficiency diseases: the role of T-lymphocytes and innate immunity. 104
The immune response to tumors as a tool toward immunotherapy 100
Skewed T-cell receptor repertoire: more than a marker of malignancy, a tool to dissect the immunopathology of inflammatory diseases 100
Common variable immunodeficiency - new insight into the pathogenesis and the quest for a workable classification. 99
Central and Mucosal Immunities are Modified by Non Adsorbable Antibiotic Treatment in Uncomplicated Diverticular Disease 99
Third-line rescue therapy for Helicobacter pylori infection 95
The importance of complying with vaccination protocols in developed countries: "anti-vax" hysteria and the spread of severe preventable diseases 93
IL-32: a newly-discovered proinflammatory cytokine 92
T-cell receptor repertoire and function in patients with Di George Syndrome and velocardiofacial syndrome. 91
Third-line rescue therapy for Helicobacter pylori infection. 90
The involvement of IgH enhancer HS1.2 in the pathogenesis of Crohn's disease: how the immune system can influence a multifactorial disease 90
TLR2: a crossroads between infections and autoimmunity? 89
The Interaction among Microbiota, Immunity, and Genetic and Dietary Factors Is the Condicio Sine Qua Non Celiac Disease Can Develop 89
Luteolin inhibits mast cell-mediated allergic inflammation. 87
Immune Modulation by Vitamin D: Special Emphasis on Its Role in Prevention and Treatment of Cancer. 87
Allele*1 of HS1,2 enhancer associates with selective IgA deficiency and IgM concentration 86
Interleukin-6 in Rheumatoid Arthritis 84
Allele *1 of HS1.2 enhancer associates with selective IgA deficiency and IgM concentration 83
New insights on the role of T cells in the pathogenesis of celiac disease. 82
Low-dose IL-2 reduces lymphocyte apoptosis and increases naive CD4 cells in HIV-1 patients treated with HAART 81
Comment on: Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system 81
New insights on the role of T-cels in the pathogenesis of Celiac Disease 81
Cellular mediators of inflammation: tregs and t(h)17 cells in gastrointestinal diseases. 81
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 79
Impact of IL-18 on inflammation 78
Cellular mediators of inflammation: tregs and TH17 cells in gastrointestinal diseases. 77
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 76
Impairment of recent thymic emigrants in HCV infection. 75
Increased osteoclastic activity in acute Charcot's osteoarthopathy: the role of receptor activator of nuclear factor-kappa B ligand 75
Current Challenges in Immunology 74
BALKAN ENDEMIC NEPHROPATHY RISK ASSOCIATES TO THE HS1.2 IG ENHANCER POLYMORPHISM 73
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 73
Melanoma antigen recognition by tumor-infiltrating T lymphocytes (TIL): effect of differential expression of melan-A/MART-1 72
Increased frequency of Ig heavy-chain HS1,2-A enhancer *2 allele in dermatitis herpetiformis, plaque psoriasis, and psoriatic arthritis. 71
Tissue infiltrating lymphocytes: the role of cytokines in their growth and differentiation. 70
Strategies to overcome obstacles to successful immunotherapy of melanoma 69
Activity of caffeic acid derivatives against Candida albicans biofilm 68
VEGF, substance P and stress, new aspects: a revisited study. 68
The impact of biological agents interfering with receptor/ligand binding in the immune system. 67
TLR2: a crossroads between infections and autoimmunity? 67
Mast cell involvement in rheumatoid arthritis. 67
Impact of Fungi on Immune Responses 67
Mast Cells Mediate Rheumatoid Arthritis-Inhibitory Role of IL-37 67
Apoptosis in asymptomatic HIV-1 seropositives immunized with HIV-1 env glycoprotein (gp160): effects of administration of Zidovudine in vivo and IL-2 in vitro 65
Luteolin, inflammation and cancer: Special emphasis on gut microbiota 65
Apoptosis in the homeostasis of the immune system and in human immune mediated diseases 64
Nerve growth factor interactions with mast cells 64
Integrins: Integrating the Biology and Therapy of Cell-cell Interactions 64
Changes in host cell molecules acquired by circulating HIV-1 in patients treated with highly active antiretroviral therapy and interleukin-2. 63
Nickel allergy in lipid transfer protein sensitized patients: Prevalence and clinical features 63
A novel autocrine pathway of tumor escape immune recognition; melanoma cell produce a soluble protein that diminuishes expression of the gene encoding the melanocyte lineage melan-A/MART-1 antigen through down modulation of its promoter. 62
High prevalence of hyperplastic colonic polyps in acromegalic subjects. 62
Strategies to overcome obstacles to successful immunotherapy of melanoma. 61
The number of HIV-DNA infected mononuclear cells is reduced under HAART plus recombinant IL-2. 60
The Italian quality control study for evaluation of CD4 cells in centres involved in the treatment of HIV-1 patients. Italian CD4 Quality Control Group 59
Abnormal synthesis of IgA in coeliac disease and related disorderd 59
Interrelationship between IL-3 and mast cells 59
IL-31 a Th2 cytokine involved in immunity and inflammation. 58
Vitamins and mast cells. 58
Vascular endothelial growth factor (VEGF), mast cells and inflammation. 58
Heat shock protein-90 inhibitors enhance antigen expression on melanomas and increase T cell recognition of tumor cells 58
Increased frequency of the immunoglobulin enhancer HS1,2 allele 2 in coeliac disease 58
Nutrition and cancer prevention 57
New insight into systemic mastocytosis mediated by cytokines IL-1 beta and IL-33: Potential inhibitory effect of IL-37 57
Biased T cell receptor repertoires in patients with chromosome 22q11.2 deletion syndrome (Di George syndrome/velocardiofacial syndrome) 56
Induction of "antigen silencing" in melanomas by oncostatin M: downmodulation of melanocyte antigen expression. 56
HIV type 1-induced inhibition of CD45 tyrosine phosphatase activity correlates with disease progression and apoptosis, but not with anti-CD3-induced T cell proliferation 56
Active thymopoiesis in idiopathic chronic pancreatitis 56
Involvment of central immunity in uncomplicated diverticular disease. 56
Comparison of beneficial actions of non-steroidal anti-inflammatory drugs to flavonoids 56
Structure and expression of the human ubiquitin fusion-degradation gene (UFD1L). 55
Impact of mast cells in rejection of allografts 55
Epatite da farmaci 54
Gut microbiota and immunity in common variable immunodeficiency: crosstalk with pro-inflammatory cytokines 54
Studies of the mechanism of cytolysis by tumour-infiltrating lymphocytes 53
Decreased CD 95 expression on naive T cells from HIV infected persons undergoing highly active antiretroviral therapy (HAART) and the influence of IL-2 low dose administration 53
IgE generation and mast cell activation 53
HCV co-infection does not affect the TREC/IL-7 pathway in HIV disease 50
Impact of mast cells on the skin. 50
Neuropeptide NGF mediates neuro-immune response and inflammation through mast cell activation 50
Impact of capsaicin on mast cell inflammation. 49
VEGF, substance P and stress, new aspects: a revisited study 49
Role of mast cells in innate and adaptive immunity. 48
Nerve growth factor interactions with mast cells 48
IL-36 receptor antagonist with special emphasis on IL-38. 47
Interrelationship between IL-3 and mast cells 47
Apoptotic effect of cyclosporin a and dexamethasone in malignant cells of patients with B-chronic lymphocytic leukemia. 46
Psychological stress and vitamins 45
Impact of IL -9 and IL-33 in mast cells 45
Totale 7.333
Categoria #
all - tutte 38.524
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.524


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020228 0 0 0 0 0 0 0 0 0 0 108 120
2020/2021996 51 107 16 111 135 76 132 24 114 16 186 28
2021/2022881 65 128 15 63 47 34 11 127 39 44 118 190
2022/20231.587 233 182 156 207 156 203 55 94 166 44 60 31
2023/2024918 30 284 25 129 27 107 23 44 21 39 93 96
2024/20251.238 46 72 146 38 107 51 18 112 298 114 236 0
Totale 7.954